Noneof the patients with CD4 count of ≥200 cells/mm3 died during follow-up and a low CD4 count at the time of TB diagnosis (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: This study was undertaken to identify subjects with human immunodeficiency virus and tuberculosis (HIV/TB)coinfection in a group of HIV-positive patients followed at five different healthcare centers, and to determine the demographic andclinical characteristics of these subjects as well as the predictors of mortality.Materials and methods: A database search for subjects with TB coinfection was performed among 1475 HIV-positive adult patients anda total of 66 individuals were identified with HIV/TB coinfection.Results: There were 66 patients (4.5%) with TB coinfection.
📊
Key Findings & Data:Twenty-one percent (n = 14) of the patients with TB coinfection diedduring the study period and these patients had significantly lower baseline CD4 counts at the time of TB diagnosis (P = 0.005).
💡
Conclusion & Impact:Noneof the patients with CD4 count of ≥200 cells/mm3 died during follow-up and a low CD4 count at the time of TB diagnosis (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background/aim: This study was undertaken to identify subjects with human immunodeficiency virus and tuberculosis (HIV/TB)coinfection in a group of HIV-positive patients followed at five different healthcare centers, and to determine the demographic andclinical characteristics of these subjects as well as the predictors of mortality.Materials and methods: A database search for subjects with TB coinfection was performed among 1475 HIV-positive adult patients anda total of 66 individuals were identified with HIV/TB coinfection.Results: There were 66 patients (4.5%) with TB coinfection. Twenty-one percent (n = 14) of the patients with TB coinfection diedduring the study period and these patients had significantly lower baseline CD4 counts at the time of TB diagnosis (P = 0.005). Noneof the patients with CD4 count of ≥200 cells/mm3 died during follow-up and a low CD4 count at the time of TB diagnosis (
🔖
Cite This Article
ALTINKAYNAK, M., GÜMÜŞER, F., AYDIN, Ö. A., VAHABOĞLU, M. H., GÜNDÜZ, A., SEVGİ, D. Y., KARAOSMANOĞLU, H. K., BÖLÜKÇÜ, S., METE, B., TABAK, Ö. F. (2022). Human immunodeficiency virus and tuberculosis coinfection: clinical features and predictors of mortality. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 503–508. https://ajindex.com/articles/610281
Friedland G, Churchyard GJ, Nardell E. Tuberculosis and HIV coinfection: current state of knowledge and research priorities. J Infect Dis 2007; 196 (Suppl. 1): S1-3. Ministry of Health. Report on the Battle against Tuberculosis in Turkey. Ankara, Turkey: Ministry of Health; 2013 (in Turkish). Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant AD, Dye C, De Cock KM, Hayes RJ, Williams BG, Churchyard GJ. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170: 673-679. Shuchman M. Improving global health--Margaret Chan at the WHO. N Engl J Med 2007; 356: 653-656.
Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restrictionfragment- length polymorphisms. N Engl J Med 1992; 326: 231-235.
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580. Selwyn PA. Issues in the clinical management of intravenous drug users with HIV infection. AIDS 1989; 3 (Suppl. 1): S201- 208. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58: 1-207.
Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR; Tuberculosis Epidemiologic Studies Consortium. The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Crit Care Med 2006; 173: 927-931.
Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, Aung H, Mugyenyi P, Ellner JJ, Whalen CW. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001; 123: 233-238.
Lopez-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, Preston-Martin S, Anastos K. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol 2007; 165: 1134-1142.
Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and